当前位置:主页 > 医学论文 > 护理论文 >

帕罗西汀联合唑吡坦治疗原发性失眠的临床疗效与安全性

发布时间:2018-05-31 17:00

  本文选题:帕罗西汀 + 唑吡坦 ; 参考:《中国临床药理学杂志》2016年09期


【摘要】:目的观察帕罗西汀联合唑吡坦与单用唑吡坦治疗原发性失眠的临床疗效与安全性。方法 57例原发性失眠患者随机分为试验组29例和对照组28例。试验组口服帕罗西汀10~20 mg·d~(-1),唑吡坦5~10 mg·d~(-1);对照组口服唑吡坦5~10 mg·d~(-1),2组疗程均为8周。治疗前后分别用多导睡眠图和匹兹堡睡眠质量指数量表评价2组的临床疗效;用不良反应症状量表(TESS)评估安全性。结果治疗后,试验组入睡时间、觉醒时间、睡眠时间分别为(29.60±4.80),(81.65±33.11),(388.75±32.81)min,显著优于对照组的(35.00±3.91),(121.29±32.48),(339.51±35.26)min(P0.05)。试验组的睡眠效率为(82.67±6.88)%,显著优于对照组的(73.69±7.01)%(P0.05)。试验组匹兹堡睡眠质量指数总分为(6.07±2.05),显著低于对照组的(8.57±2.47)(P0.05)。试验组不良反应发生率为27.59%,显著高于对照组的7.14%(P0.05)。结论帕罗西汀联合唑吡坦治疗原发性失眠患者疗效更优,且安全性高。
[Abstract]:Objective to observe the efficacy and safety of paroxetine combined with zolpidem and zolpidem alone in the treatment of primary insomnia. Methods 57 patients with primary insomnia were randomly divided into trial group (n = 29) and control group (n = 28). The experimental group was treated with paroxetine 1020 mg / d, zolpidem 10 mg / d ~ (-1) with zolpidem 10 mg / d and the control group with zolpidem 10 mg / d ~ (-1) for 8 weeks. The clinical efficacy of the two groups was evaluated by polysomnography and Pittsburgh Sleep quality Index scale before and after treatment, and the safety was evaluated with the adverse reaction symptom scale (TESS). Results after treatment, the sleep time, awakening time and sleep time in the experimental group were 29.60 卤4.80 and 388.75 卤32.81 min, respectively, which were significantly higher than those in the control group (121.29 卤32.48 min, 339.51 卤35.26 min, P 0.05). The sleep efficiency of the experimental group was 82.67 卤6.88, which was significantly better than that of the control group (73.69 卤7.01). The total score of Pittsburgh sleep quality index in the trial group was 6.07 卤2.05, which was significantly lower than that in the control group (8.57 卤2.47). The incidence of adverse reactions in the trial group was 27.59, which was significantly higher than that in the control group (7.14%, P 0.05). Conclusion Paroxetine combined with zolpidem is more effective and safe in the treatment of primary insomnia.
【作者单位】: 杭州市第七人民医院医学心理科;杭州市第七人民医院科教科;
【基金】:浙江省自然科学基金资助项目(LQ13H090003) 杭州市重点专科专病基金资助项目(20140733Q44)
【分类号】:R740

【相似文献】

相关期刊论文 前10条

1 谢永标,徐莉萍,刘破资,于瑞丽;原发性失眠患者的心理特征[J];中国行为医学科学;2005年05期

2 徐莉萍;谢永标;刘破资;岳伟华;;原发性失眠患者血浆5-羟色胺和去甲肾上腺素与心理状况的相关分析[J];中国行为医学科学;2006年03期

3 毛洪祥;;慢性原发性失眠与人格及心理因素的关系[J];中国健康心理学杂志;2008年07期

4 林勇;朱婉儿;唐建良;李婷;;慢性原发性失眠患者人格特征与家庭环境的研究[J];中国农村卫生事业管理;2010年09期

5 杨劲;黄莉莉;李巧兰;雷飞;唐向东;;原发性失眠患者的睡眠知觉分析[J];中国医药导报;2011年11期

6 王s,

本文编号:1960616


资料下载
论文发表

本文链接:https://www.wllwen.com/huliyixuelunwen/1960616.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户23cd8***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com